New $7.5M fund to advance Alzheimer's research in BC
MSFHR, Brain Canada, the Pacific Alzheimer Research Foundation, and Genome BC are very pleased to announce the creation of a $7.5 million fund for research into Alzheimer’s disease in BC.
Up to 70,000 British Columbians are affected by Alzheimer’s disease, a number that will rise as the population ages. With no truly effective therapy to prevent or cure this disease, there is an urgent need to increase support for high-quality, multidisciplinary research.
Five new projects will be funded through this opportunity, each valued at up to $1.5 million.
MSFHR initiated the creation of the partnership with $1.5 million from the Government of British Columbia targeted to advance research in the province into biological causes and therapeutic treatments for Alzheimer’s disease.
Genome BC is contributing $1 million to advance translational or clinical research with a genomics component into direct benefits for patients.
The Pacific Alzheimer Research Foundation is contributing $1.25 million for research focused on biological causes and therapeutic treatments for Alzheimer’s disease and related dementias.
Brain Canada will match the other partners’ contributions dollar for dollar with funds from the Canada Brain Research Fund, a public-private partnership between Brain Canada and the Government of Canada.
“MSFHR is proud to have initiated this partnership to accelerate discovery by BC researchers of new approaches to prevention, diagnosis and treatment of this devastating disease,” says Dr. Diane Finegood, MSFHR president and CEO.
“I hope that families with loved ones experiencing Alzheimer’s disease are encouraged to know that highly-qualified researchers in BC are receiving more support to solve the mysteries surrounding dementia. This collaboration will build upon the nationally recognized research already conducted in BC to find cures and treatments for this degenerative disorder.”
This collaboration builds on recent work by the partners to support BC researchers in neurology. Last month, MSFHR and Genome BC contributed a total of $600,000 to two Brain Canada grants totalling $3 million awarded to UBC researchers (Dr. Neil Cashman and Dr. Terence Snutch) leading interprovincial teams investigating brain diseases including ALS (also known as Lou Gehrig’s disease, epilepsy, and autism).
Applications will be reviewed by Brain Canada. A Request for Applications is available on the Brain Canada website and includes more information for researchers interested in applying for this grant.
|Call for applications||December 18, 2013|
|Deadline for receipt of letters of intent||February 11, 2014|
|Invitation to submit full application issued||April 7, 2014|
|Deadline for receipt of applications||June 30, 2014|
|Notification of award||August 25, 2014|
|Funding begins||Earliest date: October 1, 2014|